Right now, all over the World, multiple Health Systems are negotiating with numerous Manufacturers, but existing Health System policy considerations are inhibiting progress.

That is why Remedium, together with our partners, have launched AIM4ALL, the Access to Innovative Medicines for All Initiative, to solve the problem of pricing once and for all.

Instead of multiple lengthy negotiations based on limited data and disputed assumptions:

Imagine a World in which there is an expanding network of like-minded Health Systems, with willing clinicians and the necessary IT capabilities, able to record patient outcomes accurately and price medicines based on their real-world performance (either on a patient-by-patient or patient cohort basis) over time.

Imagine a World in which negotiations are based on a set of standard (by product archetype) framework agreements where patient outcomes are king.

Imagine a World in which Manufacturers can bring forward and lock in their returns by insuring the performance of their products at acceptable cost.

This is the AIM4ALL (+Remedium) World, a World in which Health Systems are guaranteed value for money and Manufacturers can de-risk their returns without loss of value.

But how would this work in practice?